Biomarkers in Drug Design

Indian Society for Clinical Organization, Tech Association of British Pharmaceutical Industry Researchers have been able to find an increasing number of critical molecular drivers of cancer growth thanks to advances in cancer molecular characterization. These drug discoveries have resulted in a number of novel anticancer therapies as well as scientific advancement in specific patient populations. Despite this, the identification of clinically meaningful response biomarkers is still a work in progress. We discuss methodologies for cancer molecular characterization and the role of biomarkers in the development of innovative anticancer treatments in this review.

Any new biomarkers discovered and evaluated should preferably adhere to the Clinical Laboratory Improvement Amendments (CLIA) and Good Clinical Laboratory Practice (GCLP) standards.

 

  • Oncology and Infectious Diseases Medicine Development
  • Drug Discovery Innovation and Strategies
  • Drug discovery using computational chemistry and informatics

Related Conference of Biomarkers in Drug Design

April 17-18, 2024

14th International Conference on Chemistry Meeting

Paris, France
June 25-26, 2024

13th World Congress on Chromatography

Toronto, Canada
August 22-23, 2024

16th International Conference on Clinical Chemistry

Berlin, Germany
December 18-19, 2024

4th International Conference on Petrochemistry and Natural Gas

Amsterdam, Netherlands

Biomarkers in Drug Design Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in